EXECUTIVE EMPLOYMENT AGREEMENT BY AND BETWEEN HORIZON THERAPEUTICS PLC AND HORIZON THERAPEUTICS USA, INC. AND SEAN CLAYTONAgreement by And • March 1st, 2022 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • Illinois
This Executive Employment Agreement (hereinafter referred to as the “Agreement”), is entered into by and between Horizon Therapeutics plc, an Irish Public Limited Company, and its wholly owned subsidiary, Horizon Therapeutics USA, Inc., a Delaware corporation, having a principal place of business at 1 Horizon Way, Deerfield IL 60015, (hereinafter referred to together as the “Company”) and Sean Clayton (hereinafter referred as to the “Executive”). The terms of this Agreement shall be effective commencing February 28, 2022 (the “Effective Date”).
RELEASE AND WAIVER OF CLAIMSNon-Competition Agreement • March 1st, 2022 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations
In consideration of the payments and other benefits set forth in Section 4.4 of the Executive Employment Agreement dated May 7, 2015, as amended by the First Amendment to Executive Employment Agreement dated May 4, 2017, (the “Employment Agreement”), to which this form is attached, and the payments and other benefits set forth in Exhibit A, attached hereto, I, Brian Beeler, hereby furnish Horizon Therapeutics PLC, and Horizon Therapeutics USA, Inc. (together the “Company”), with the following release and waiver (“Release and Waiver”).
Master Manufacturing Services Agreement October 15, 2018Product Agreement • March 1st, 2022 • Horizon Therapeutics Public LTD Co • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
